RAPT Therapeutics, Inc. RAPT
RAPT
RAPT Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. FULC
Fulcrum Therapeutics, Inc. KROS
Keros Therapeutics, Inc. PHAT
Phathom Pharmaceuticals, Inc. PMVP
PMV Pharmaceuticals, Inc. RENB
Lunai Bioworks Inc. REPL
Replimune Group, Inc. RVMD
Revolution Medicines, Inc. STOK
Stoke Therapeutics, Inc.
RAPT Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. FULC
Fulcrum Therapeutics, Inc. KROS
Keros Therapeutics, Inc. PHAT
Phathom Pharmaceuticals, Inc. PMVP
PMV Pharmaceuticals, Inc. RENB
Lunai Bioworks Inc. REPL
Replimune Group, Inc. RVMD
Revolution Medicines, Inc. STOK
Stoke Therapeutics, Inc.
Performance
| Periode | RAPT | EWTX | FULC | KROS | PHAT | PMVP | RENB | REPL | RVMD | STOK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 272.94 % | 30.60 % | 232.34 % | 29.31 % | 142.62 % | 49.08 % | -62.33 % | -38.48 % | 35.12 % | 333.48 % |
| YTD | 97.62 % | -44.82 % | 84.71 % | -1.07 % | 61.53 % | -15.03 % | -81.39 % | -64.00 % | 9.69 % | 170.01 % |
| 1Y | 66.90 % | -53.13 % | 150.42 % | -73.97 % | -22.51 % | -13.33 % | -74.23 % | -57.62 % | -1.94 % | 138.48 % |
| 3Y | -85.58 % | 39.52 % | 13.02 % | -65.67 % | 18.76 % | -89.33 % | -92.72 % | -74.53 % | 152.96 % | 138.85 % |
| 5Y | -91.78 % | -50.28 % | -21.16 % | -66.47 % | -70.06 % | -96.38 % | -95.82 % | -81.69 % | 8.36 % | -22.07 % |
| 10Y | -75.22 % | -50.28 % | -33.78 % | -21.56 % | -51.87 % | -96.53 % | -97.59 % | -70.17 % | 67.01 % | 19.01 % |
| Depuis le début | -75.22 % | -50.28 % | -33.78 % | -21.56 % | -51.87 % | -96.53 % | -97.59 % | -70.17 % | 67.01 % | 19.01 % |